Clinical trial
Mexiletine for the Treatment of Focal Dystonia
NCT00001784 is registered in ClinicalTrials.gov with National Institute of Neurological Disorders and Stroke (NINDS) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Mexiletine for the Treatment of Focal Dystonia
- Lead sponsor
- National Institute of Neurological Disorders and Stroke (NINDS)
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- July 31, 1998
- Completion date
- July 31, 2002
- Enrollment
- 24
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.